Drug Side Effects
Search
FOLLICULAR LYMPHOMA STAGE III
FOLLICULAR LYMPHOMA STAGE III
was reported 40 times
These drug classes are most commonly taken by patients reporting FOLLICULAR LYMPHOMA STAGE III:
#
Drug
Count
0
CD20-directed Cytolytic Antibody [EPC]
13
1
Corticosteroid [EPC]
11
2
Alkylating Drug [EPC]
9
3
Nucleoside Metabolic Inhibitor [EPC]
7
4
Platinum-based Drug [EPC]
6
5
Atypical Antipsychotic [EPC]
3
6
Folate Analog Metabolic Inhibitor [EPC]
2
7
Janus Kinase Inhibitor [EPC]
2
8
Kinase Inhibitor [EPC]
2
9
Topoisomerase Inhibitor [EPC]
2
10
BCL-2 Inhibitor [EPC]
1
11
Bispecific CD20-directed CD3 T Cell Engager [EPC]
1
12
CD19-directed Chimeric Antigen Receptor [EPC]
1
13
Expectorant [EPC]
1
14
Genetically-modified Autologous T Cells [EPC]
1
15
Interleukin-4 Receptor alpha Antagonist [EPC]
1
16
Leukocyte Growth Factor [EPC]
1
17
Nonsteroidal Anti-inflammatory Drug [EPC]
1
18
Thalidomide Analog [EPC]
1